Skip to main content
Caplight Logo









Avkin

Avkin

Private
Newport, DelawareHealthcare & Life Scienceshttps://avkin.com/

Last Round

Angel

Nov 27, 2019

Total Funding Raised

$275,000

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Avkin is a healthcare technology company that manufactures wearable simulators for realistic clinical training to improve patient safety.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Patient Engagement

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

medical simulationwearable medical simulatorsstandardized patientSPhigh-fidelity simulationhealthcare simulationnursing simulationhuman patient simulationclinical simulationsimulation hardwaremanikin alternativeprocedural skills trainingpatient communicationhaptic feedbacksimulation consultingbirthing simulatortelehealth simulation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Avkin Comparables

Compare Avkin with similar companies based on industry and business-model similarity.

Avkin comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medical-X
82%
Remedy Simulation Group
81%
3B Scientific
80%

Avkin Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AngelNov 27, 2019
GrantSep 18, 2019
GrantMay 6, 2019

Key People

Founding team and executive leadership

Amy Bucha

Co-Founder And COO

Founding Team

Amy Cowperthwait CEO

Founder and CEO Patient-Centered Simulation Training Authority 2016 Hayden Vanguard Recipient

Founding Team

Avkin Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 62% MoM.

  • Jul 13, 2026

    Open roles increased to 8, representing 29% of headcount.

Avkin Filings

Explore SEC and related filing metadata, where available.

Avkin filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Avkin's valuation, stock price, and market status.

Is Avkin a public or private company?

Avkin is a private company.

What is the current stock price of Avkin?

Avkin is a private company with no public stock price. No recent secondary market data is available.

How much is Avkin worth (valuation)?

Valuation information for Avkin is not publicly available.

Can I buy Avkin stock?

Avkin shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Avkin's last funding round?

Avkin's most recent funding round was Angel on November 27, 2019.

Who are the main investors in Avkin?

Key investors in Avkin include Delaware Division of Small Business, Science Center, Martinson Ventures.

Will Avkin IPO soon?

No public IPO plans have been announced for Avkin.

How can I track Avkin secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Avkin's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNewport, Delaware
Employee Range24
Year Founded2015
Last FundingNov 27, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?